Ignite Creation Date:
2024-05-06 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04697628
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-18
First Post:
2021-01-04
Brief Title:
Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
Sponsor:
Seagen Inc
Organization:
Seagen Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-08-05
Completion Date Type:
ESTIMATED
First Submit Date:
2021-01-04
First Submit QC Date:
January 4 2021
Study First Post Date:
2021-01-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-16
Last Update Post Date:
2024-06-18
Last Update Post Date Type:
ACTUAL